| (Values in U.S. Thousands) | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 | Dec, 2019 |
| Sales | 19,240 | 15,560 | 13,860 | 7,580 | 3,840 |
| Sales Growth | +23.65% | +12.27% | +82.85% | +97.40% | +57.38% |
| Net Income | -8,150 | -10,720 | -10,370 | -11,560 | -10,710 |
| Net Income Growth | +23.97% | -3.38% | +10.29% | -7.94% | -3.78% |
Myomo Inc (MYO)
5.34 x 2 6.00 x 2
Pre-market by (Cboe BZX)
5.43 -0.44 (-7.50%) 03/12/25 [NYSE Arca]
5.34 x 2 6.00 x 2
Pre-market 5.35 -0.08 (-1.47%) 05:07 ET
for Wed, Mar 12th, 2025
Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro(R) product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals. Myomo, Inc. is headquartered in Cambridge,Massachusetts.
Fiscal Year End Date: 12/31